NHS gets 12 years to roll out new weight-loss drug
We’ve had to make this difficult decision in order to protect vital NHS services and also to test ways of delivering this new ...
Major blow to patients waiting for new NHS jab - only 10% will get it straight away
To help the NHS manage demand, the health organisation's spending watchdog said about 220,000 people could benefit from the ...
Eli Lilly’s Obesity Drug Set for Slow NHS Rollout in England
England’s National Health Service will begin rolling out Eli Lilly & Co.’s blockbuster weight-loss drug Mounjaro over the next few months, though the medication will initially be made available to ...
Britain drug-cost watchdog says it will recommend Lilly obesity drug
Britain's drugs cost-effectiveness watchdog NICE said on Thursday it will recommend Eli Lilly's obesity drug Mounjaro be made available to around 220,000 people in the country via the state health ...
STAT2h
U.K. to restrict Eli Lilly’s obesity drug to patients with greatest need
The U.K. will soon offer Eli Lilly's Mounjaro for people with obesity — but only to a small share of those medically eligible ...
devdiscourse2h
NICE Greenlights Mounjaro: A Milestone for Britain's Obesity Battle
NICE has recommended Eli Lilly's obesity drug Mounjaro for around 220,000 people in the UK via the state health system over ...
AOL2h
Obese people ‘will have to wait’ for weight loss jab Mounjaro, NHS officials warn
The NHS spending watchdog has recommended Mounjaro – also known as tirzepatide and made by Eli Lilly – for those with a body ...
Millions to be denied NHS fat jabs as treatment is limited to just 220,000 - fewer than one in ten patients who meet criteria
Fewer than one in ten patients who meet the criteria for Mounjaro will be given it by the health service over the next three ...
FiercePharma3h
For first phase of Mounjaro's obesity rollout in England, only a limited number of patients will have access
Following its endorsement of Eli Lilly’s obesity medicine tirzepatide, England’s National Institute for Health and Care ...
Shares in Eli Lilly rise as Zepbound weight-loss study shows solid success
Lilly said patients taking Zepbound lost about 20% of their weight on average compared with nearly 14% for Wegovy. The drug ...
NHS Mounjaro warning as 90 per cent of people will be disappointed
The NHS spending watchdog has recommended Mounjaro – also known as tirzepatide and made by Eli Lilly – for those with a body ...